NeoFOL-R Trial (Perioperative Versus Adjuvnat FOLFIRINOX in Resectable Pancreatic Cancer) | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
NeoFOL-R Trial (Perioperative Versus Adjuvnat FOLFIRINOX in Resectable Pancreatic Cancer)	Effects of Chemotherapy; Neoadjuvant Chemotherapy; Resectable Pancreatic Cancer	Recruiting	Phase 3	2024-11-27		NCT05529940

5 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Gangnam Severance Hospital	33
Seoul National University Bundang Hospital	114
Seoul National University Hospital	277
Seoul St. Mary's Hospital	31
SMG-SNU Boramae Medical Center	26

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Department of Internal Medicine, Seoul St. Mary's Hospital, Catholic University College of Medicine	Seoul	South Korea	1
Department of Surgery, Seoul National University College of Medicine	Seoul	South Korea	3